Capital Research Global Investors Takeda Pharmaceutical CO LTD Transaction History
Capital Research Global Investors
- $463 Billion
- Q3 2024
A detailed history of Capital Research Global Investors transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Capital Research Global Investors holds 13,137,204 shares of TAK stock, worth $172 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
13,137,204
Previous 13,126,608
0.08%
Holding current value
$172 Million
Previous $170 Million
9.9%
% of portfolio
0.04%
Previous 0.04%
Shares
15 transactions
Others Institutions Holding TAK
# of Institutions
338Shares Held
73.8MCall Options Held
1.96MPut Options Held
165K-
Morgan Stanley New York, NY5.35MShares$70.2 Million0.01% of portfolio
-
Mondrian Investment Partners LTD London, X05.09MShares$66.8 Million1.21% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA4.64MShares$60.8 Million0.05% of portfolio
-
Goldman Sachs Group Inc New York, NY4.56MShares$59.8 Million0.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.41MShares$44.7 Million0.02% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $40.8B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...